About the Study This study is assessing whether a new targeted therapy (olomorasib) in combination with standard of care anti-cancer drugs (including immunotherapy and chemotherapy) is more effective than just …
CONDITION: Cancer
GENDER: Both males and females
AGE GROUP: 18 and above
TRIAL STATUS: Recruiting
About the Study The main purpose of this study is to test a potential new treatment for early breast cancer. The study will measure how well a new hormone therapy …
CONDITION: Cancer
GENDER: All
AGE GROUP: 18 and above
TRIAL STATUS: Recruiting
The purpose of this study is to determine if BHV-1300 is a safe treatment in participants with Graves’ Disease and to explore its effect on disease-specific biomarkers.
CONDITION: Metabolic and Endocrine
GENDER: Both males and females
AGE GROUP: 18 to 65 years
TRIAL STATUS: Recruiting
Do you have moderate to severe knee pain from osteoarthritis? You may be eligible to join a clinical study of a potential new treatment. Why this trial matters Osteoarthritis can …
CONDITION: Musculoskeletal
GENDER: Both males and females
AGE GROUP: 18 to 85 years
TRIAL STATUS: Recruiting
Novatrials is enrolling volunteers with cardiovascular disease, and are living with obesity, in a clinical study of a potential new treatment that may help improve heart health outcomes. You may …
CONDITION: Cardiovascular
GENDER: Both males and females
AGE GROUP: 45 to 85 years
TRIAL STATUS: Recruiting
Novatrials is seeking volunteers who are overweight to join a clinical study of a potential new weight loss treatment. Under expert medical supervision, participants will explore an innovative new treatment …
CONDITION: Diet and Nutrition
GENDER: Both males and females
AGE GROUP: 18 to 65 years
TRIAL STATUS: Recruiting
In Australia, 2,000 people a day are treated for skin cancer and 2 in 3 Australians will be diagnosed with skin cancer by the age of 70. Your participation supports research designed …
CONDITION: Cancer
GENDER: Both males and females
AGE GROUP: 18 to 85 years
TRIAL STATUS: Recruiting
A Phase 1a/1b, Blinded, Placebo-Controlled Study of the Safety, Tolerability and Pharmacokinetics of Single- and Multiple-Ascending Doses of ABI-5366 in Healthy Subjects and in Subjects who are Seropositive for HSV-2 …
CONDITION: Other
GENDER: All
AGE GROUP: 18 to 60 years
TRIAL STATUS: Recruiting
Australian researchers are testing an investigational drug for Parkinson’s disease symptoms such as motor fluctuations and dyskinesia. This is a 20 week study, in which you will be treated at …
CONDITION: Neurological
GENDER: Both males and females
AGE GROUP: 30 and above
TRIAL STATUS: Recruiting
REZOLV3R is a randomised, double-blind, multi-centre trial treating symptomatic patients with recurrent malignant ascites suitable for paracentesis and a paracentesis-free interval of 28 days or less. The aim of the …
CONDITION: Cancer
GENDER: Both males and females
AGE GROUP: 18 and above
TRIAL STATUS: Recruiting
Australian researchers are testing a potential new treatment for obesity and weight-related comorbidities in adolescents. This is a 76 week study and may include up to 23 visits. Your adolescent …
CONDITION: Diet and Nutrition
GENDER: All
AGE GROUP: 12 to 17 years
TRIAL STATUS: Recruiting
The objective of ASPIRE-AF is to assess the feasibility of a randomized controlled trial of non-vitamin K oral anticoagulants versus usual care in patients with perioperative atrial fibrillation (AF) after …
CONDITION: Cardiovascular
GENDER: Both males and females
AGE GROUP: 55 and above
TRIAL STATUS: Recruiting
This international, multicentre, pragmatic, double-blind, placebo-controlled, randomised trial of TxA versus placebo will enrol 3,300 patients throughout Australia and internationally. This is an effectiveness trial – some elements of the …
CONDITION: Anaesthesiology
GENDER: Both males and females
AGE GROUP: 18 and above
TRIAL STATUS: Recruiting
Australian researchers are testing a potential new treatment for atopic dermatitis (eczema) in children. This is a 36 week study with at least 12 separate visits. Your child will be …
CONDITION: Skin
GENDER: All
AGE GROUP: 6 to 17 years
TRIAL STATUS: Recruiting
Aims: to document the efficacy and safety outcomes of SCS in persons with chronic, chemotherapy-induced peripheral neuropathy Types of chemotherapy: Taxotere, Oxaliplatin, Paclitaxel Primary outcome measure: % responder rate at …
CONDITION: Cancer
GENDER: Both males and females
AGE GROUP: 18 to 100 years
TRIAL STATUS: Recruiting
Patients presenting to the emergency department with acute ischemic stroke, who are are eligible for standard intravenous thrombolytic therapy within 4.5 hours of stroke onset will be assessed for major …
CONDITION: Stroke
GENDER: Both males and females
AGE GROUP: 18 and above
TRIAL STATUS: Recruiting
VAPOR-C is a randomised study of the impact of IV versus inhaled anaesthesia (propofol versus sevoflurane) and lidocaine versus no lidocaine on duration of disease free survival inpatients with either …
CONDITION: Anaesthesiology
GENDER: Both males and females
AGE GROUP: 18 and above
TRIAL STATUS: Recruiting
About this clinical trial: Wesley Medical Research is seeking research participants for a study evaluating the safety and tolerability of an investigational drug for Amyotrophic lateral sclerosis (ALS) and how …
CONDITION: Neurological
GENDER: Both males and females
AGE GROUP: 18 to 75 years
TRIAL STATUS: Recruiting
*** This trial is conducted online *** Psychological distress in people diagnosed with cancer is common and can have a number of negative consequences for affected people, including a reduced …
CONDITION: Mental Health
GENDER: Females
AGE GROUP: 18 and above
TRIAL STATUS: Recruiting
Project Title: Role of Sympathetic Activation in Ischemia Reperfusion Injury The aim of the study is to investigate the effectiveness of remote ischemic preconditioning (RIPC) in healthy male individuals. …
CONDITION: Cardiovascular
GENDER: Males
AGE GROUP: 60 to 75 years
TRIAL STATUS: Recruiting